corresponding to a sequence of active and inactive esters were synthesised and evaluated for anticonvulsant activity. With two exceptions, ethyl 4-[(4-cyanophenyl)amino]-6-methyl-2-oxocyclohex-3-ene-1-carboxylate (1k), and 3-[N-(4-cyanophenyl)amino]-5-methyl-2-cyclohexenone (3g), and ethyl 4-(phenylamino)-6-methyl-2-cyclohexenone (1n), and 3-N-(phenylamino)-5-methyl-2-cyclohexenone (3j), anticonvulsant screening
试图进一步研究烯胺酮的潜在抗惊厥活性,以发现代谢产物作为烯胺酮的酯的活性/共活性实体的可能作用。合成了一系列5-甲基-2-
环己烯烯酮,它们是假设的代谢产物,对应于一系列活性和非活性酯,并评估了其抗惊厥活性。4-[(4-
氰基苯基)
氨基] -6-甲基-2-氧代环己基-3-烯-1-
羧酸乙酯(1k)和3- [N-(4-
氰基苯基)
氨基] -5 -惊厥药-甲基-2-
环己烯酮(3g)和乙基4-(苯
氨基)-6-甲基-2-
环己烯酮(1n)和3-N-(苯基
氨基)-5-甲基-2-
环己烯酮(3j)筛选数据是平行的,酯及其推定的脱羧类似物显示出相似的活性。本系列中评估最活跃的类似物,4-[(4-
氯苯基)
氨基] -6-甲基-2-氧代环己基-3-烯-1-
羧酸乙酯(1e),其ED(50)为16.7 mg kg(-1)和TD(小鼠最大电击发作(
MES)测试中110.7 mg kg(-1)(保护指数,
PI = TD(50)/